The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to announce its request for proposals (RFP) for breakthrough “Accelerator Grants” to advance its vital mission to cure neuroendocrine cancers. NETRF is launching this new Accelerator Program specifically designed to fund research with the potential to transform our understanding of intestinal carcinoid and pancreatic neuroendocrine cancers and/or have substantial promise to lead to improved treatments and diagnostics for patients.
NETRF is seeking proposals for significant NET research projects, with each grant award of up to $1.2 million paid over a four-year period. Specifically, we are seeking investigators and teams with the tools to study neuroendocrine tumor biology in creative, sustained ways that have heretofore not been pursued. We are open to proposals from a broad array of disciplines including, but not limited to, investigations in genetic and epigenetic profiling, intensive analysis of cell biology and protein expression, immune microenvironment of tumors, development of faithful disease models or any other area with an impact on the biology of neuroendocrine tumors. We are interested in a broad set of topics, with the main focus on proposals specific to intestinal and pancreatic neuroendocrine cancers. If your interest lies outside this field, we may also consider proposals in the rarer forms of neuroendocrine cancers.
In funding “Accelerator Grants,” NETRF seeks to connect and convene the strongest teams of researchers to harvest their data, cross-fertilize their learning, and create a virtual dream team of top investigators all working toward finding cures for neuroendocrine cancers.
Systematic Evaluation of the Immune Environment of Neuroendocrine Tumors
The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to announce a new funding opportunity to characterize the immune microenvironment of carcinoid and pancreatic neuroendocrine tumors. We are eager to explore the possibility that immune based therapies may be useful in treating neuroendocrine tumor patients and therefore are inviting applicants to apply to study the immune microenvironment of neuroendocrine tumor samples.
We expect to award multiple grants of $100,000 each, paid over a one-year period. Applications are invited from investigators with access to suitable clinical tumor samples to submit proposals to systematically characterize the immune environment and the genomes of the same neuroendocrine tumor samples. Applications are invited from researchers currently in the field of neuroendocrine tumor research, as well as from investigators with experience in immune characterization. Each application must include an investigator with expertise in immunology.
The lack of well-validated and widely accepted cell lines derived from intestinal carcinoid and pancreatic neuroendocrine tumors (PNET) is a significant barrier for research and development of new therapies. The Neuroendocrine Tumor Research Foundation therefore wishes to stimulate a concerted effort to create a “collection” of well-characterized cell lines that faithfully replicate tumor characteristics and genetics. The Foundation has partnered with the Rare Cancer Research Foundation (RCRF), a foundation dedicated to curing rare cancers through strategic investments and innovative collaborations, and the American Type Culture Collection (ATCC), the world’s largest non-profit cell line repository, to establish a Neuroendocrine Tumor Cell Line collection in their catalog. This challenge requires written documentation, detailed description of each cell line, and sample delivery.
As a result of our ongoing collaboration with the American Association for Cancer Research (AACR), we have awarded grants to investigators pursuing innovative ideas and approaches that have a direct application and relevance to carcinoid or pancreatic neuroendocrine cancer. As the world’s largest cancer research membership organization, the AACR, with its funding commitment from the NET Research Foundation, solicits innovative neuroendocrine proposals from its over 35,000 members. This grant has been open to researchers currently in the field, as well as investigators with experience in other areas of cancer research. Research areas may be basic, translational, clinical or epidemiological in nature. All responses to the international request for proposals are put through a rigorous peer review process, in order to select the highest rated proposal.
Please check back soon for NETRF-AACR grant opportunities.
NET Research Foundation
20 Park Plaza, Suite 478
Boston, MA 02116